bendamustine hydrochloride 25 MG Injection [Treanda]

RxCUI
1805009
RxNorm name
bendamustine hydrochloride 25 MG Injection [Treanda]
Display name
TREANDA (Injectable)
Full name
bendamustine hydrochloride 25 MG Injection [Treanda]
Term type
SBD
Status
Active
Strength
25 mg
Dose form
Injection
Route
Injectable
Updated
2026-10-24 12:46:53

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
092016
Active start
092016
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
bendamustine hydrochloride25 MG / 1 EACHbendamustinebendamustine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Injection1649574

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
bendamustine134547

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRTreanda 25 MG Injection1NAMES
RxNorm Namebendamustine hydrochloride 25 MG Injection [Treanda]1NAMES
RxNorm SynonymTreanda 25 MG Injection1NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID39d53698-57fa-7c99-fc5b-f52a556848261CODES
RxCUI18050091CODES
MMSL_CODEBD258721CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
63459-390-0863459-390TREANDA Bendamustine HydrochlorideCephalon, LLCNDA022249

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
NDA02224963459-390TREANDA Bendamustine HydrochlorideNDACephalon, LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11SourceActive
63459039008rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TREANDABENDAMUSTINE HYDROCHLORIDECephalon, LLC39d53698-57fa-7c99-fc5b-f52a556848262022-10-31Warnings, Adverse reactionsExact identifier
ndc (package): 63459-390-08
ndc (product): 63459-390
ndc11 (package): 63459039008
rxcui: 1805009

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
39d53698-57fa-7c99-fc5b-f52a55684826TREANDA 25 MG Injection [PSN] · bendamustine hydrochloride 25 MG Injection [Treanda] [SBD] · Treanda 25 MG Injection [SY]326These highlights do not include all the information needed to use TREANDA safely and effectively. See full prescribing information for TREANDA. TREANDA ® (bendamustine hydrochloride) injection, for intravenous use TREANDA ® (bendamustine hydrochloride) for injection, for intravenous use Initial U.S. Approval: 200820221027

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
39d53698-57fa-7c99-fc5b-f52a55684826These highlights do not include all the information needed to use TREANDA safely and effectively. See full prescribing information for TREANDA. TREANDA ® (bendamustine hydrochloride) injection, for intravenous use TREANDA ® (bendamustine hydrochloride) for injection, for intravenous use Initial U.S. Approval: 2008Cephalon, LLC20221031
39d53698-57fa-7c99-fc5b-f52a55684826These highlights do not include all the information needed to use TREANDA safely and effectively. See full prescribing information for TREANDA. TREANDA ® (bendamustine hydrochloride) injection, for intravenous use TREANDA ® (bendamustine hydrochloride) for injection, for intravenous use Initial U.S. Approval: 2008Cephalon, LLC20221027
3e124168-70fe-4304-b9a6-ad01a887e744National Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCL01AANitrogen mustard analoguesATC1-4bendamustine
FDASPLN0000175558Alkylating DrugEPChas_epcbendamustine
FDASPLN0000000236Alkylating ActivityMOAhas_moabendamustine
MEDRTD000069461Bendamustine HydrochlorideCHEMhas_ingredientbendamustine hydrochloride
MEDRTD000069461Bendamustine HydrochlorideCHEMhas_ingredientbendamustine
MEDRTD004342Drug HypersensitivityDISEASEci_withbendamustine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withbendamustine
MEDRTD007945Leukemia, LymphoidDISEASEmay_treatbendamustine hydrochloride
MEDRTD007945Leukemia, LymphoidDISEASEmay_treatbendamustine
MEDRTD008228Lymphoma, Non-HodgkinDISEASEmay_treatbendamustine hydrochloride
MEDRTD008228Lymphoma, Non-HodgkinDISEASEmay_treatbendamustine
MEDRTN0000000236Alkylating ActivityMOAhas_moabendamustine hydrochloride
MEDRTN0000000236Alkylating ActivityMOAhas_moabendamustine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH25 MG (expressed as bendamustine hydrochloride)
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESNDANDA022249
NAMESPrescribable SynonymTREANDA 25 MG Injection
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon